Schedule 13D ownership disclosure

Arcutis Biotherapeutics Inc

Security class unavailable · CUSIP: 03969K108

Event date: 2022-05-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-162372
Form type
SC 13D/A
Filer
Arcutis Biotherapeutics, Inc.
CIK
CIK 1787306
Filed
May 27, 2022
Reporting period
May 25, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub